|FDA grants QIDP status to Taksta for bacterial skin infections|
As an oral tablet formulation, Taksta (sodium fusidate, Cempra) has demonstrated activity against gram-positive bacteria, including all Staphylococcus aureus strains, such as health care-associated MRSA and community-associated MRSA. Based on phase 2 ...
Healio - Wed, 30 Sep 2015 06:18
|Prevention of Catheter-Related Bloodstream Infections, 2015|
The CDC/NHSN's surveillance data define a CLABSI for surveillance purposes as a laboratory-confirmed bloodstream infection in any patient with a central venous catheter (CVC) present either at the time of, or within a 48-hour period before, the ...
Infectious Disease Special Edition - Fri, 02 Oct 2015 13:48
|US FDA Approves JUVEDERM® ULTRA XC for Use in Lips|
These products should not be used in patients who have severe allergies, marked by a history of anaphylaxis or history or presence of multiple severe allergies, and should not be used in patients with a history of allergies to gram-positive bacterial ...
MarketWatch - Thu, 01 Oct 2015 04:07
|Data From New Studies Confirm In Vitro Potency of VIBATIV Against Gram ...|
Researchers showed that VIBATIV possessed the greatest in vitro activity of all antibiotics evaluated against a broad collection of contemporary Gram-positive clinical isolates that caused complicated skin and skin structure infections (cSSSIs) in U.S ...
Benzinga - Mon, 21 Sep 2015 05:00
|Theravance Biopharma (TBPH) Announces Presentation of Positive VIBATIV Data ...|
StreetInsider.com - Mon, 21 Sep 2015 05:00
|Data From New Studies Confirm In Vitro Potency of VIBATIV(R) (Telavancin ...|
Stockhouse - Mon, 21 Sep 2015 05:00
|Paratek Expands Leadership Team With Two New Hires|
BOSTON, Oct. 1, 2015 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) has expanded its senior leadership team with two new hires. The company announced today that Regina Paglia has joined as Senior Vice President, Human ...
Nasdaq - Thu, 01 Oct 2015 04:26
|FDA Grants Qualified Infectious Disease Product Designation to Taksta(TM ...|
Cempra is developing Taksta (fusidic acid) exclusively in the U.S. for acute bacterial skin and skin structure infections (ABSSSI) and is exploring its use for the long term oral treatment for refractory bone and joint infections, including prosthetic ...
MarketWatch - Fri, 18 Sep 2015 03:52
|Cempra's CEM-102 tagged a Qualified Infectious Disease Product by FDA|
Seeking Alpha - Fri, 18 Sep 2015 05:11
|The Medicines Company Announces Participation at IDWeek 2015 Meeting|
ORBACTIV® is indicated for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused or suspected to be caused by susceptible isolates of the following gram-positive microorganisms: Staphylococcus aureus ...
Business Wire (press release) - Thu, 01 Oct 2015 03:52
|'Antibiotic addict' India losing fight against lethal bacteria|
"We're seeing unprecedented resistance to these precious antibiotics globally, and especially in India. If these trends continue, infections that could once be treated in a week or two could become routinely life threatening and endanger millions of ...
Times of India - Wed, 16 Sep 2015 16:10
|New Technologies Under Development To Combat Antibiotic Resistant Organisms|
Seeking Alpha - Wed, 16 Sep 2015 10:40